Evidence map›Paper›PMID 30117172›Full record

ArticleJournal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine2019

Contrast-Enhanced Transrectal Ultrasound for Follow-up After Focal HIFU Ablation for Prostate Cancer.

Andre L de Castro Abreu, Akbar N Ashrafi, Inderbir S Gill, Masakatsu Oishi, Matthew W Winter, Daniel Park, Vinay Duddalwar, Mariana C Stern, Suzanne L Palmer, Manju Aron and 1 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Effect of High-Intensity Focused Ultrasound Versus Plasma Radiofrequency Ablation on Recurrent Allergic Rhinitis.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Trial
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Andre L de Castro AbreuUSC Institute of Urology, University of Southern California, Los Angeles, California, USA.
Akbar N AshrafiUSC Institute of Urology, University of Southern California, Los Angeles, California, USA.
Inderbir S GillUSC Institute of Urology, University of Southern California, Los Angeles, California, USA.
Masakatsu OishiUSC Institute of Urology, University of Southern California, Los Angeles, California, USA.
Matthew W WinterUSC Institute of Urology, University of Southern California, Los Angeles, California, USA.
Daniel ParkUSC Institute of Urology, University of Southern California, Los Angeles, California, USA.
Vinay DuddalwarDepartment of Radiology, University of Southern California, Los Angeles, California, USA.
Mariana C SternUSC Institute of Urology, University of Southern California, Los Angeles, California, USA.
Suzanne L PalmerDepartment of Radiology, University of Southern California, Los Angeles, California, USA.
Manju AronDepartment of Pathology, University of Southern California, Los Angeles, California, USA.
Mittul GulatiDepartment of Radiology, University of Southern California, Los Angeles, California, USA.
University of Southern California · US

Funding

Diagnosing clinically-significant prostate cancer in African American men: Systematic random versus MR-image-fusion guided biopsyR01CA205058 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GILL, INDERBIR, STERN, MARIANA C · 2016 to 2019
$2.1M
National Institutes of Health/National Cancer Institute R01 CA205058-01NCI NIH HHS R01 CA205058
6 · The paper itself

Abstract

The optimal strategy for imaging after focal therapy for prostate cancer is evolving. This series is an initial report on the use of contrast-enhanced transrectal ultrasound (TRUS) in follow-up of patients after high-intensity focused ultrasound (HIFU) hemiablation for prostate cancer. In 7 patients who underwent HIFU hemiablation, contrast-enhanced TRUS findings were as follows: (1) contrast-enhanced TRUS clearly showed the HIFU ablation defect as a sharply marginated nonenhancing zone in all patients; (2) contrast-enhanced TRUS identified suspicious foci of recurrent enhancement within the ablation zone in 2 patients, facilitating image-guided prostate biopsy, which showed prostate cancer; and (3) contrast-enhanced TRUS findings correlated with multiparametric magnetic resonance imaging and biopsy histologic findings.

Indexed as

Contrast MediaHigh-Intensity Focused Ultrasound AblationAdultAgedAged, 80 and overFollow-Up StudiesHumansImage EnhancementMaleMiddle AgedProstateProstatic NeoplasmsTreatment OutcomeUltrasonographyContrast Mediacontrast-enhanced ultrasoundfocal therapyhigh-intensity focused ultrasoundprostate cancertransrectal ultrasound

Identifiers

PMID30117172
PMCPMC9721530
OpenAlexW2885733447

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.